Method and compositions for producing granules containing high concentrations of biologically active substances

• US 20040265378A1
• Filed: 06/16/2004
• Published: 12/30/2004
• Est. Priority Date: 06/25/2003
• Status: Abandoned Application

• Current Assignee: University of Tennessee Research Foundation (University of Teesside)
• Original Assignee: University of Tennessee Research Foundation (University of Teesside)
• Inventors: Johnson, James R., Peng, Yingxu, Shukla, Atul J., Sun, Yichun
• Application Number:
  US10/869,180
• Publication Number:
  US 20040265378A1
• Time in Patent Office: Days
• US Class Current: 424/464
• CPC Class Codes: A61K 9/145 with organic compounds
• CPC Class Codes: A61K 9/146 with organic macromolecular compounds
• CPC Class Codes: A61K 9/2077 Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Abstract

A method for making granules containing a biologically active substance (BAS) whereby the BAS is mixed with a binder to form a powder mixture having a concentration of binder below that which, when the binder is melted, will cause over-wetting of the powder mixture, heating the mixture to a temperature above the melting point of the binder to form an agglomerated powder, and forming granules from the agglomerated powder. The granules may be used to make pharmaceutical dosage forms such as tablets and capsules.

Claims

1. A method for preparing granules containing one or more biologically active substances (BAS) comprising mixing a binder with the BAS to obtain a powder mixture, heating the powder mixture to a temperature above the melting point of the binder to obtain an agglomerated powder, wherein the concentration of the binder in the powder mixture is at least that which will agglomerate the powder mixture when the binder is melted and is below that which will result in over-wetting of the powder mixture when the binder is melted, and permitting granules to form from the agglomerated powder.

2. The method of claim 1 wherein the heating of the powder mixture to a temperature above the melting point of the binder is from circulating hot liquid, hot air or steam, microwave or infrared sources, heating tape, high-shear mixing, rotating pan, extruder, fluidized bed granulator, or low shear mixing.

3. The method of claim 1 wherein the temperature is below the melting point of the BAS.

4. The method of claim 1 wherein the melting point of the binder is between 30°

C. and 200°

C.

5. The method of claim 1 wherein granules are formed from the mixture without subjecting the mixture to external pressure.

6. The method of claim 1 wherein the BAS is a non-compressible BAS.

7. The method of claim 6 wherein the BAS is selected from the group consisting of ibuprofen, acetaminophen, aspirin, naproxen, antibiotics, ketoprofen, indomethacin, ranitidine, sucralfate, vitamin C, probucol, nicotinic acid, aminocaproic acid, pentoxyfylline, quinidine gluconate, nifedipine, verapamil hydrochloride, cholestyramine, metoproplol tartrate, tocainamide hydrochloride, ethotoin, phenacemide, and carbidopa.

8. The method of claim 7 wherein the BAS is selected from the group consisting of ibuprofen, acetaminophen, and aspirin.

9. The method of claim 6 wherein the concentration of BAS in the granules is 80% or higher.

10. The method of claim 6 wherein the concentration of BAS in the granules is 85% or higher.

11. The method of claim 6 wherein the concentration of BAS in the granules is 90% or higher.

12. The method of claim 6 wherein the concentration of BAS in the granules is 95% or higher.

13. The method of claim 1 wherein the binder is polyethylene glycol.

14. The method of claim 1 wherein the binder is a waxy solid or semisolid.

15. The method of claim 14 wherein the binder is selected from the group consisting of stearic acid, poloxamers, glycerylesters of fatty acids, and hydrogenated vegetable oils.

16. The method of claim 1 which additionally comprises mixing with the BAS and the binder one or more excipients selected from the group consisting of filler, flavor, color, disintegrant, glidant, and lubricant.

17. A granule made by the method of claim 1.

20. A method for making tablets containing one or more biologically active substances (BAS) comprising compressing a multiplicity of the granules produced by the method of claim 1 into tablets.

21. The method of claim 20 which additionally comprises mixing with the BAS and the binder one or more excipients selected from the group consisting of filler, flavor, color, disintegrant, glidant, and lubricant.

25. A method for making capsules containing one or more biologically active substances (BAS) comprising encapsulating a multiplicity of the granules produced by the method of claim 1 into capsules.

26. The method of claim 25 which additionally comprises mixing with the BAS and the binder one or more excipients selected from the group consisting of filler, flavor, color, disintegrant, glidant, and lubricant.

18. A method for making tablets containing one or more biologically active substances (BAS) comprising mixing a binder with the BAS to obtain a powder mixture, heating the powder mixture to a temperature above the melting point of the binder to obtain an agglomerated powder, wherein the concentration of the binder in the powder mixture is at least that which will agglomerate the powder mixture when the binder is melted and is below that which will result in over-wetting of the powder mixture when the binder is melted, permitting granules to form from the agglomerated powder, and compressing the granules into tablets.

19. The method of claim 18 which additionally comprises mixing with the BAS and the binder one or more excipients selected from the group consisting of filler, flavor, color, disintegrant, glidant, and lubricant.

22. A tablet made by the method of claim 18.

23. A method for making capsules containing one or more biologically active substances (BAS) comprising mixing a binder with the BAS to obtain a powder mixture, heating the powder mixture to a temperature above the melting point of the binder to obtain an agglomerated powder, wherein the concentration of the binder in the powder mixture is at least that which will agglomerate the powder mixture when the binder is melted and is below that which will result in over-wetting of the powder mixture when the binder is melted, permitting granules to form from the agglomerated powder, and encapsulating the granules into capsules.

24. The method of claim 23 which additionally comprises mixing with the BAS and the binder one or more excipients selected from the group consisting of filler, flavor, color, disintegrant, glidant, and lubricant.

27. A capsule made by the method of claim 23.

28. A granule comprising one or more biologically active substances (BAS) and a binder, wherein the concentration of BAS in the granule is 80% or higher.

29. The granule of claim 28 wherein the concentration of BAS in the granule is 85% or higher.

30. The granule of claim 28 wherein the concentration of BAS in the granule is 90% or higher.

31. The granule of claim 28 wherein the concentration of BAS in the granule is 95% or higher.

32. The granule of claim 28 wherein the BAS is a non-compressible BAS.

33. The granule of claim 32 wherein the BAS is selected from the group consisting of ibuprofen, acetaminophen, aspirin, naproxen, antibiotics, ketoprofen, indomethacin, ranitidine, sucralfate, vitamin C, probucol, nicotinic acid, aminocaproic acid, pentoxyfylline, quinidine gluconate, nifedipine, verapamil hydrochloride, cholestyramine, metoproplol tartrate, tocainamide hydrochloride, ethotoin, phenacemide, and carbidopa.

34. The granule of claim 33 wherein the BAS is selected from the group consisting of ibuprofen, acetaminophen, and aspirin.

35. A tablet comprising one or more biologically active substances (BAS) and a binder, wherein the concentration of BAS in the tablet is 80% or higher.

36. The tablet of claim 35 wherein the concentration of BAS in the tablet is 85% or higher.

37. The tablet of claim 35 wherein the concentration of BAS in the tablet is 90% or higher.

38. The tablet of claim 35 wherein the concentration of BAS in the tablet is 95% or higher.

39. The tablet of claim 35 wherein the BAS is a non-compressible BAS.

40. The tablet of claim 37 wherein the BAS is selected from the group consisting of ibuprofen, acetaminophen, aspirin, naproxen, antibiotics, ketoprofen, indomethacin, ranitidine, sucralfate, vitamin C, probucol, nicotinic acid, aminocaproic acid, pentoxyfylline, quinidine gluconate, nifedipine, verapamil hydrochloride, cholestyramine, metoproplol tartrate, tocainamide hydrochloride, ethotoin, phenacemide, and carbidopa.

41. The tablet of claim 40 wherein the BAS is selected from the group consisting of ibuprofen, acetaminophen, and aspirin.